Meglitinide

Known as: 4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid, meglitinide [Chemical/Ingredient], meglitinides 
A benzamide belonging to the meglitinide class of antidiabetic agents with hypoglycemic activity. Meglitinide represents the basic structure of the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Patients with type 2 diabetes mellitus have a twofold increased risk of cardiovascular mortality compared with non-diabetic… (More)
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
This report presents an algorithm to assist primary care physicians, endocrinologists, and others in the management of adult… (More)
  • figure 1
Is this relevant?
Review
2004
Review
2004
The sulphonylureas act by triggering insulin release from the pancreatic β cell. A specific site on the adenosine triphosphate… (More)
  • figure 1
Is this relevant?
Review
2003
Review
2003
The expression meglitinide analogs was introduced in 1995 to cover new molecules proposed as non-sulfonylurea insulinotropic… (More)
Is this relevant?
Review
2002
Review
2002
Sulfonylureas are widely used to treat type 2 diabetes because they stimulate insulin secretion from pancreatic beta-cells. They… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2001
Review
2001
The loss of early-phase insulin secretion is an important and early event in the natural history of type 2 diabetes. Because a… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2000
Review
2000
Type 2 diabetes mellitus is a complex heterogenous metabolic disorder in which peripheral insulin resistance and impaired insulin… (More)
Is this relevant?
1997
1997
Several meglitinide analogs are currently under investigation as potential insulinotropic tools for the treatment of noninsulin… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1989
1989
Sulfonylureas inhibit an ATP-dependent K+ channel in the B-cell plasma membrane and thereby initiate insulin release. Diazoxide… (More)
Is this relevant?
1988
1988
The influence of the hypoglycemic drugs tolbutamide, meglitinide, glipizide and glibenclamide on ATP-dependent K+ currents of… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?